These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 696780)

  • 21. Cervical ripening with prostaglandin E2 vaginal suppositories.
    Buchanan D; Macer J; Yonekura ML
    Obstet Gynecol; 1984 May; 63(5):659-63. PubMed ID: 6585733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal death associated with induction of labour with intravaginal prostaglandin E2. Case report.
    Simmons K; Savage W
    Br J Obstet Gynaecol; 1984 Jun; 91(6):598-9. PubMed ID: 6587905
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral labor induction with PGE2-tablets].
    Bogdan C; Balmer JA; Liechti A
    Zentralbl Gynakol; 1978; 100(8):510-15. PubMed ID: 664975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
    Bailey CD; Newman C; Ellinas SP; Anderson GG
    Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 in a diaphragm. A further note.
    Schulman H; Saldana L
    Prostaglandins; 1977 Apr; 13(4):751-3. PubMed ID: 854583
    [No Abstract]   [Full Text] [Related]  

  • 26. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
    Boehm FH; Killam AP; Chambers JF; Davidson KK
    Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Labor induction with prostaglandin E2 in high-risk pregnancy].
    Andreev Zh; Borisov I
    Akush Ginekol (Sofiia); 1982; 21(1):70-8. PubMed ID: 7044168
    [No Abstract]   [Full Text] [Related]  

  • 30. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical ripening with intravaginal prostaglandin E2 gel.
    MacKenzie IZ; Embrey MP
    Br Med J; 1977 Nov; 2(6099):1381-4. PubMed ID: 338109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of labor with prostaglandin E2 vaginal suppositories.
    Macer J; Buchanan D; Yonekura ML
    Obstet Gynecol; 1984 May; 63(5):664-8. PubMed ID: 6585734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine rupture with the use of vaginal prostaglandin E2 for induction of labor.
    Claman P; Carpenter RJ; Reiter A
    Am J Obstet Gynecol; 1984 Dec; 150(7):889-90. PubMed ID: 6594931
    [No Abstract]   [Full Text] [Related]  

  • 34. A simpler approach to labor induction using lipid-based prostaglandin E2 vaginal suppository.
    MacKenzie IZ; Bradley S; Embrey MP
    Am J Obstet Gynecol; 1981 Sep; 141(2):158-62. PubMed ID: 6945046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of maternal side effects from prostaglandins used for cervical ripening.
    Goodlin RC; Reschl L; Clewell WH
    J Reprod Med; 1986 Dec; 31(12):1095-7. PubMed ID: 3467066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the elective induction of labor with oral Prostaglandin E2.
    Visscher RD; Struyk CD; Visscher HC
    Obstet Gynecol; 1977 Jan; 49(1):15-9. PubMed ID: 556643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
    Gruber WS; Baumgarten K
    Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of labor with PGE2 vagina suppositories.
    Fuselier PG; Wittcoff H
    J La State Med Soc; 1977 Jul; 129(7):175-7. PubMed ID: 908861
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of labor with oral prostaglandin E2.
    Gabet HA; Brinton J; Brown B
    Am J Obstet Gynecol; 1976 Jun; 125(3):333-8. PubMed ID: 1275023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.